MAETZOLD DEREK J sold CSTL

November 18, 2025 · Form 4 insider transaction

MAETZOLD DEREK J sold 2,678 shares of Castle Biosciences, Inc. at $34.02 per share, a transaction worth $91.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
2,678
Price
$34.02
Total value
$91.1K
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 18, 2025
Filing dateNovember 20, 2025
Shares owned after50,937
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 8, 2025.; This transaction was executed in multiple trades at prices ranging from $33.79 to $34.16, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

View the original Form 4 on SEC EDGAR
MAETZOLD DEREK J sold CSTL: November 18, 2025 | Insider Trading Screener